Neurology® Podcast

Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections

03.28.2024 - By American Academy of NeurologyPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Dr. Shuvro Roy talks with Dr. Annette Langer-Gould about the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks. Read the related article in Neurology: Neuroimmunology and Neuroinflammation.  Disclosures can be found at Neurology.org.

More episodes from Neurology® Podcast